
Spero Therapeutics Inc (SPRO) with a beta value of 1.45 appears to be a promising investment opportunity.
On Friday, Spero Therapeutics Inc (NASDAQ: SPRO) was 3.50% up from the session before settling in for the closing price of $2.0. A 52-week range